严重肥胖患者的FIB-4可靠性:需要更低的切割值吗?
Victoria Green1, Joanne Lin1, Morgan McGrath2
1Departments of Internal Medicine.
Journal of clinical gastroenterology
|November 20, 2023
概括
修订后的FIB-4评分可以在接受腹手术的严重肥胖患者中改善晚期肝纤维化的检测. 传统的FIB-4切断值错过了与代谢功能障碍相关的脂肪性肝病和晚期纤维化病患者.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 腹部外科 腹部外科
- 非侵入性肝脏疾病评估
背景情况:
- 肝脏活检是纤维化评估的标准,但存在局限性,特别是在严重肥胖的情况下.
- 非侵入性FIB-4评分用于初步查晚期纤维化风险.
- 在代谢功能障碍相关的脂肪性肝病 (MASLD) 和严重肥胖症中,FIB-4的适用性和切断精度尚不确定.
研究的目的:
- 为了探索FIB-4分数和手术内肝脏活检之间的相关性.
- 评估传统与拟议的FIB-4截止值在接受腹手术的重度肥胖患者中的精度.
主要方法:
- 分析了接受减肥手术的632名严重肥胖患者.
- 进行了手术前的振动控制过渡性弹性成像和手术内肝脏活检.
- 传统和拟议的FIB-4截止值使用AUC分析进行了比较.
主要成果:
- 拟议的FIB-4切割值将高级纤维化检测的AUC从0.5748增加到0.6899.
- 拟议的切断值正确识别了40名患有晚期纤维化 (F3-F4) 的患者,而传统的切断值错过了.
- 传统的FIB-4切断值不足以在这个人群中识别晚期纤维化.
结论:
- 目前的FIB-4切断值不足以查严重肥胖的MASLD患者的晚期纤维化.
- 对于诊断高风险患者,应考虑修订的FIB-4评分.
- 精确的纤维化分期对于管理肥胖患者肝病进展至关重要.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
115
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
115
Obesity
507
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
507


